Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin versus co-trimoxazole prophylaxis in multiple myeloma
IRCT20141209020258N75Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jul 2016
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple myeloma (MM) comparing Ciprofloxacin prophylaxis with Co-trimoxazole prophylaxis (2 arms). Primary endpoint: Effect of ciprofloxacin versus co-trimoxazole in preventing infections during treatment. Started Jul 2016; status: completed.
02
Drugs
ciprofloxacintrimethoprim + sulfamethoxazole
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on IRCT20141209020258N75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N75.